Sunday, April 20, 2025

Monthly Archives: April, 2020

Five Oxford COVID-19 projects receive UKRI funding

April 20,2020: "Five projects from across Oxford University's Medical Sciences Division are amongst twenty-one new studies into the novel coronavirus which have been funded...

Alembic Pharmaceuticals announces USFDA Tentative Approval for Alcaftadine Ophthalmic Solution, 0.25%.

April 20, 2020: "Alembic Pharmaceuticals Limited (Alembic) announced it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated...

Bristol Myers Squibb Announces Positive Topline Result from Pivotal Phase 3 Trial Evaluating Opdivo® (nivolumab) plus Yervoy® (ipilimumab) vs. Chemotherapy in Previously Untreated Malignant...

April 20, 2020: “Bristol-Myers Squibb announced that CheckMate -743, a pivotal Phase 3 trial evaluating Opdivo Â® (nivolumab) in combination with Yervoy Â® (ipilimumab) in previously untreated malignant pleural mesothelioma (MPM) met its primary endpoint...

Interim phase 1 data evaluating MOv18 IgE, an anti-folate receptor alpha IgE antibody, in cancer patients with advanced solid tumours to be presented at...

April 20, 2020: "Epsilogen, a global leader in the development of immunoglobulin E (IgE) antibodies to treat cancer, today announces that interim data from...

Epsilogen licences MOv18 IgE, an anti-folate receptor alpha IgE antibody from King’s College London

April 20, 2020: "Epsilogen, a global leader in the development of immunoglobulin E (IgE) antibodies to treat cancer announces that it has in-licenced exclusive...

WHO guidance helps detect iron deficiency and protect brain development

April 20, 2020: “Detecting iron deficiency early during pregnancy and in young children is crucial. Iron deficiency in children under two years of age...

Sanofi to present Phase 2 detailed results of its brain-penetrant BTK inhibitor in relapsing multiple sclerosis

April 17, 2020: "Sanofi will host a scientific session to present detailed data from their Phase 2b trial evaluating its investigational BTK (Bruton’s tyrosine...

Novartis to study hydroxychloroquine for Covid-19

April 20, 2020: Novartis has entered an agreement with the US FDA to conduct a Phase III clinical trial of hydroxychloroquine to treat hospitalised patients with...

New research to assess extent of coronavirus infection in children and teenagers

April 20, 2020: "New research funded by the NIHR and UK Research and Innovation (UKRI) will assess rates of coronavirus infection and immunity in...

Oxford project receives funding to assess novel coronavirus infection rates in children and teenagers across the UK.

April 20, 2020: "A multi-site project, called ‘What’s the STORY?’ has received funding from UK Research and Innovation (UKRI) to assess no vel coronavirus...

NIH to launch public-private partnership to speed COVID-19 vaccine and treatment options

April 17, 2020: "The National Institutes of Health and the Foundation for the NIH (FNIH) are bringing together more than a dozen leading biopharmaceutical...

Coronavirus treatment: Vaccines and drugs in the pipeline for COVID-19

As of April-2020, There are 5 vaccine candidates and 21 drug candidates are under the clinical stage of development There are more than 70 drug...
- Advertisment -

Most Read